SEC Form 4 · accession 0001615774-15-000023
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Greenberg
Officer — Chief Executive Officer · Director
Period of report
Jan 1, 2015
Accepted (ET)
Jan 5, 2015 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2015 | M | 59,063 | $4.75 | A | 363,063 | D | |
| Common StockF2,F3 | Jan 1, 2015 | F | 27,344 | $10.26 | D | 335,719 | D | |
| Common StockF4,F3,F5 | Jan 1, 2015 | F | 12,055 | $10.26 | D | 323,664 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option(b)F6 | $4.25 | holding | — | — | — | — | Jan 1, 2017 | Common Stock | 125,000 | 125,000 | D |
| Option(c)F6 | $4.75 | holding | — | — | — | — | Sep 1, 2015 | Common Stock | 150,000 | 150,000 | D |
| Option(d)F6 | $4.75 | holding | — | — | — | — | Jan 1, 2016 | Common Stock | 17,969 | 17,969 | D |
| Option(e)F6 | $5.00 | holding | — | — | — | — | May 1, 2016 | Common Stock | 8,223 | 8,223 | D |
| Option(f)F6 | $5.00 | holding | — | — | — | — | Jan 1, 2017 | Common Stock | 30,265 | 30,265 | D |
| Option(g)F6 | $5.00 | holding | — | — | — | — | Feb 1, 2018 | Common Stock | 23,750 | 23,750 | D |
| Option(h)F6 | $5.00 | holding | — | — | — | — | Nov 1, 2018 | Common Stock | 150,000 | 150,000 | D |
| Option(i)F6 | $5.00 | holding | — | — | — | — | Feb 1, 2019 | Common Stock | 33,750 | 33,750 | D |
| Option(j)F6 | $5.00 | holding | — | — | — | — | Feb 1, 2020 | Common Stock | 53,125 | 53,125 | D |
| Option(k)F6 | $5.00 | holding | — | — | — | — | Feb 1, 2020 | Common Stock | 50,625 | 50,625 | D |
| Option(l)F7 | $5.00 | holding | — | — | — | — | Mar 1, 2021 | Common Stock | 41,563 | 41,563 | D |
| Option(m)F8 | $5.00 | holding | — | — | — | — | Mar 1, 2022 | Common Stock | 29,063 | 29,063 | D |
Explanation of responses
- F1Dr. Greenberg exercised 59,063 vested options (which otherwise would have expired on January 1, 2015) reported as Option(2) on Form 3 filed with the SEC on November 18, 2014.
- F2Dr. Greenberg tendered 27,344 shares of common stock to the Company in accordance with Rule 16b-3.
- F3The fair market value on the day of the exercise.
- F4The Company withheld 12,055 shares to cover taxes.
- F5After giving effect to (i) exercise of 59,063 options, (ii) tendering to the Company 27,344 shares for the exercise of 59,063 options, and (iii) withholding by Company of 12,055 shares to cover taxes, Dr. Greenberg acquired net 19,664 shares.
- F6These are vested employee options currently exercisable.
- F7Includes 31,172 options currently exercisable and 10,391 options that will vest and become exercisable in the next 60 days.
- F8Includes 19,375 options currently exercisable and 9,688 options that will vest and become exercisable in the next 60 days.
Remarks
Excludes unvested employee options in amount of 471,221 shares, not exercisable for over 60 days from this date.